Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02927912

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

Multi-institution Phase II Trial of Intraoperative Electron Beam Radiotherapy Boost at the Time of Breast Conserving Surgery With Oncoplastic Reconstruction in Women With Early-Stage Breast Cancer

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This phase II trial studies the side effects of intraoperative electron beam radiotherapy boost and to see how well it works in treating patients with stage I-II breast cancer undergoing surgery with reconstruction. Giving a single dose of electron beam radiation to the tumor cavity during the breast surgery before reconstruction may be a better way to kill tumor cells and shrink tumors.

Detailed description

PRIMARY OBJECTIVES: I. To determine the rate of grade 3 breast fibrosis at 1 year in women undergoing lumpectomy with oncoplastic reconstruction and immediate intraoperative electron radiotherapy boost followed by adjuvant whole breast radiotherapy. SECONDARY OBJECTIVES: I. To determine the rate of 5 year ipsilateral breast tumor recurrence rate. II. To determine the change in self-reported cosmesis using the Breast Cancer Treatment Outcome Scale (BCTOS) questionnaire. III. To evaluate physician-reported cosmetic outcomes using the 4-point Harvard Cosmesis Scale and digital photographs. OUTLINE: Patients undergo standard of care lumpectomy and then undergo 1 fraction of intraoperative electron beam radiation therapy (IOERT) boost to the lumpectomy cavity. Patients then undergo standard of care oncoplastic reconstruction and whole breast radiation therapy. After completion of study treatment, patients are followed up at 1 month, 6 months, 1 year, and every year thereafter for 5 years.

Conditions

Interventions

TypeNameDescription
RADIATIONElectron Beam TherapyUndergo IOERT boost
PROCEDURELumpectomyUndergo lumpectomy
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies
RADIATIONRadiation TherapyUndergo whole breast radiation therapy
PROCEDUREReconstructive SurgeryUndergo oncoplastic reconstruction

Timeline

Start date
2017-10-16
Primary completion
2025-05-08
Completion
2026-11-30
First posted
2016-10-07
Last updated
2026-02-17

Locations

5 sites across 2 countries: United States, Canada

Regulatory

Source: ClinicalTrials.gov record NCT02927912. Inclusion in this directory is not an endorsement.